| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | NCOA3 ARID1B DTX1 ZMIZ2 GPS2 MAML1 MAML2 BCL9 ARID1A MAML3 EP300 ZIC3 | 1.34e-09 | 303 | 75 | 12 | GO:0003713 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 1.90e-08 | 46 | 75 | 6 | GO:0030020 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 5.40e-07 | 18 | 75 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | NCOA3 ARID1B DTX1 ZMIZ2 GPS2 MAML1 MAML2 BCL9 ARID1A MAML3 EP300 ZIC3 | 1.14e-06 | 562 | 75 | 12 | GO:0003712 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 3.51e-06 | 28 | 75 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | NCOA3 PAG1 ARID1B DTX1 ZMIZ2 GPS2 TNRC6A DAB2 MAML1 COL14A1 MAML2 BCL9 ARID1A MAML3 EP300 ZIC3 | 5.03e-06 | 1160 | 75 | 16 | GO:0030674 |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 8.22e-06 | 11 | 75 | 3 | GO:0098973 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | NCOA3 PAG1 ARID1B DTX1 ZMIZ2 GPS2 TNRC6A DAB2 MAML1 COL14A1 MAML2 BCL9 ARID1A MAML3 EP300 BBLN ZIC3 | 8.59e-06 | 1356 | 75 | 17 | GO:0060090 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.10e-05 | 37 | 75 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 1.84e-05 | 42 | 75 | 4 | GO:0098918 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 7.55e-05 | 188 | 75 | 6 | GO:0005201 | |
| GeneOntologyMolecularFunction | structural molecule activity | COL2A1 COL4A3 POTEE COL4A6 COL16A1 MRPL12 COL21A1 POTEF PCLO NPAP1 COL14A1 POTEI | 1.13e-04 | 891 | 75 | 12 | GO:0005198 |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.40e-04 | 70 | 75 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 2.33e-04 | 32 | 75 | 3 | GO:0099186 | |
| GeneOntologyMolecularFunction | chromatin binding | 4.28e-04 | 739 | 75 | 10 | GO:0003682 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.02e-03 | 118 | 75 | 4 | GO:0003774 | |
| GeneOntologyMolecularFunction | clathrin binding | 1.72e-03 | 63 | 75 | 3 | GO:0030276 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 1.81e-03 | 599 | 75 | 8 | GO:0050839 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 2.53e-03 | 20 | 75 | 2 | GO:0061665 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 2.79e-03 | 21 | 75 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 6.82e-03 | 33 | 75 | 2 | GO:0050681 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor binding | 7.22e-03 | 34 | 75 | 2 | GO:0050750 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription of Notch receptor target | 1.47e-06 | 7 | 73 | 3 | GO:0007221 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | NCOA3 SFPQ EGR2 MED28 ZMIZ2 GPS2 EHF DAB2 MAML1 CHD6 MAML2 SSBP4 BCL9 MAML3 EP300 ZIC3 | 2.24e-05 | 1390 | 73 | 16 | GO:0045944 |
| GeneOntologyCellularComponent | collagen trimer | 6.90e-07 | 88 | 74 | 6 | GO:0005581 | |
| GeneOntologyCellularComponent | dynein complex | 4.00e-05 | 54 | 74 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | chromatin | POTEE NCOA3 ARID1B SFPQ EGR2 RBL1 POTEF ZMIZ2 EHF ADNP2 RHOXF1 CHD6 POTEI ARID1A EP300 SLX4 | 4.88e-05 | 1480 | 74 | 16 | GO:0000785 |
| GeneOntologyCellularComponent | complex of collagen trimers | 5.41e-05 | 21 | 74 | 3 | GO:0098644 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 9.26e-05 | 25 | 74 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | FACIT collagen trimer | 1.84e-04 | 6 | 74 | 2 | GO:0005593 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 1.84e-04 | 6 | 74 | 2 | GO:0005587 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 1.96e-04 | 32 | 74 | 3 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 1.96e-04 | 32 | 74 | 3 | GO:0043189 | |
| GeneOntologyCellularComponent | transcription regulator complex | 2.49e-04 | 596 | 74 | 9 | GO:0005667 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 3.41e-04 | 8 | 74 | 2 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 3.41e-04 | 8 | 74 | 2 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 3.41e-04 | 8 | 74 | 2 | GO:0098645 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 3.47e-04 | 94 | 74 | 4 | GO:0000123 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 4.06e-04 | 272 | 74 | 6 | GO:0090575 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 5.09e-04 | 104 | 74 | 4 | GO:0031248 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 5.43e-04 | 45 | 74 | 3 | GO:1902562 | |
| GeneOntologyCellularComponent | paraspeckles | 5.46e-04 | 10 | 74 | 2 | GO:0042382 | |
| GeneOntologyCellularComponent | inner dynein arm | 5.46e-04 | 10 | 74 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | bBAF complex | 5.46e-04 | 10 | 74 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 6.08e-04 | 109 | 74 | 4 | GO:1902493 | |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 9.40e-04 | 13 | 74 | 2 | GO:1990907 | |
| GeneOntologyCellularComponent | npBAF complex | 1.09e-03 | 14 | 74 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | brahma complex | 1.09e-03 | 14 | 74 | 2 | GO:0035060 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 1.15e-03 | 332 | 74 | 6 | GO:0005788 | |
| GeneOntologyCellularComponent | nBAF complex | 1.44e-03 | 16 | 74 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | cytoplasmic region | 1.73e-03 | 360 | 74 | 6 | GO:0099568 | |
| GeneOntologyCellularComponent | fibrillar center | 2.29e-03 | 156 | 74 | 4 | GO:0001650 | |
| GeneOntologyCellularComponent | clathrin coat of coated pit | 2.49e-03 | 21 | 74 | 2 | GO:0030132 | |
| GeneOntologyCellularComponent | microtubule associated complex | 2.57e-03 | 161 | 74 | 4 | GO:0005875 | |
| GeneOntologyCellularComponent | supramolecular polymer | COL2A1 COL4A3 POTEE COL4A6 DYNC2H1 POTEF DNAH2 POTEI DNAH8 DNAH7 BBLN | 2.94e-03 | 1187 | 74 | 11 | GO:0099081 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | NCOA3 ARID1B SFPQ PYGO2 MED28 NPAP1 CSTF2 BCL9 ARID1A NONO SLX4 CSTF2T | 3.11e-03 | 1377 | 74 | 12 | GO:0140513 |
| GeneOntologyCellularComponent | mRNA cleavage and polyadenylation specificity factor complex | 3.80e-03 | 26 | 74 | 2 | GO:0005847 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 5.04e-03 | 30 | 74 | 2 | GO:0016514 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 5.33e-03 | 317 | 74 | 5 | GO:0032838 | |
| GeneOntologyCellularComponent | mRNA cleavage factor complex | 5.38e-03 | 31 | 74 | 2 | GO:0005849 | |
| GeneOntologyCellularComponent | axoneme | 6.26e-03 | 207 | 74 | 4 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 6.37e-03 | 208 | 74 | 4 | GO:0097014 | |
| Domain | Neuroggenic_mastermind-like_N | 5.73e-08 | 3 | 73 | 3 | IPR019082 | |
| Domain | MamL-1 | 5.73e-08 | 3 | 73 | 3 | PF09596 | |
| Domain | MamL-1 | 5.73e-08 | 3 | 73 | 3 | SM01275 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.09e-07 | 14 | 73 | 4 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.09e-07 | 14 | 73 | 4 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.09e-07 | 14 | 73 | 4 | IPR013602 | |
| Domain | DHC_N2 | 2.09e-07 | 14 | 73 | 4 | PF08393 | |
| Domain | MT | 2.09e-07 | 14 | 73 | 4 | PF12777 | |
| Domain | AAA_8 | 2.09e-07 | 14 | 73 | 4 | PF12780 | |
| Domain | DHC_fam | 2.84e-07 | 15 | 73 | 4 | IPR026983 | |
| Domain | Dynein_heavy_dom | 2.84e-07 | 15 | 73 | 4 | IPR004273 | |
| Domain | Dynein_heavy | 2.84e-07 | 15 | 73 | 4 | PF03028 | |
| Domain | Collagen | 9.91e-07 | 85 | 73 | 6 | IPR008160 | |
| Domain | Collagen | 9.91e-07 | 85 | 73 | 6 | PF01391 | |
| Domain | RRM | 2.05e-06 | 217 | 73 | 8 | SM00360 | |
| Domain | RRM_dom | 2.87e-06 | 227 | 73 | 8 | IPR000504 | |
| Domain | RRM | 3.16e-06 | 230 | 73 | 8 | PS50102 | |
| Domain | DHC_N1 | 3.16e-06 | 8 | 73 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 3.16e-06 | 8 | 73 | 3 | IPR013594 | |
| Domain | - | 4.89e-06 | 244 | 73 | 8 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 7.37e-06 | 258 | 73 | 8 | IPR012677 | |
| Domain | BAF250_C | 1.51e-05 | 2 | 73 | 2 | IPR033388 | |
| Domain | CSTF2_hinge | 1.51e-05 | 2 | 73 | 2 | IPR025742 | |
| Domain | BAF250_C | 1.51e-05 | 2 | 73 | 2 | PF12031 | |
| Domain | CSTF2_hinge | 1.51e-05 | 2 | 73 | 2 | PF14327 | |
| Domain | CSTF_C | 1.51e-05 | 2 | 73 | 2 | PF14304 | |
| Domain | BAF250/Osa | 1.51e-05 | 2 | 73 | 2 | IPR021906 | |
| Domain | CSTF_C | 1.51e-05 | 2 | 73 | 2 | IPR026896 | |
| Domain | RRM_1 | 1.68e-05 | 208 | 73 | 7 | PF00076 | |
| Domain | ATPase_dyneun-rel_AAA | 2.02e-05 | 14 | 73 | 3 | IPR011704 | |
| Domain | AAA_5 | 2.02e-05 | 14 | 73 | 3 | PF07728 | |
| Domain | Actin_CS | 3.09e-05 | 16 | 73 | 3 | IPR004001 | |
| Domain | ACTINS_2 | 3.75e-05 | 17 | 73 | 3 | PS00432 | |
| Domain | Actin/actin-like_CS | 4.48e-05 | 18 | 73 | 3 | IPR020902 | |
| Domain | NOPS | 4.51e-05 | 3 | 73 | 2 | PF08075 | |
| Domain | NOPS | 4.51e-05 | 3 | 73 | 2 | IPR012975 | |
| Domain | ACTINS_ACT_LIKE | 5.31e-05 | 19 | 73 | 3 | PS01132 | |
| Domain | TSPN | 9.59e-05 | 23 | 73 | 3 | SM00210 | |
| Domain | C4 | 2.24e-04 | 6 | 73 | 2 | SM00111 | |
| Domain | - | 2.24e-04 | 6 | 73 | 2 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 2.24e-04 | 6 | 73 | 2 | IPR001442 | |
| Domain | Nuc_rcpt_coact | 2.24e-04 | 6 | 73 | 2 | IPR009110 | |
| Domain | C4 | 2.24e-04 | 6 | 73 | 2 | PF01413 | |
| Domain | NC1_IV | 2.24e-04 | 6 | 73 | 2 | PS51403 | |
| Domain | Actin | 2.38e-04 | 31 | 73 | 3 | IPR004000 | |
| Domain | Actin | 2.38e-04 | 31 | 73 | 3 | PF00022 | |
| Domain | ACTIN | 2.38e-04 | 31 | 73 | 3 | SM00268 | |
| Domain | Laminin_G | 1.52e-03 | 58 | 73 | 3 | IPR001791 | |
| Domain | - | 1.53e-03 | 15 | 73 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 1.53e-03 | 15 | 73 | 2 | SM00501 | |
| Domain | ARID_dom | 1.53e-03 | 15 | 73 | 2 | IPR001606 | |
| Domain | ARID | 1.53e-03 | 15 | 73 | 2 | PS51011 | |
| Domain | ARID | 1.53e-03 | 15 | 73 | 2 | PF01388 | |
| Domain | AAA+_ATPase | 2.44e-03 | 144 | 73 | 4 | IPR003593 | |
| Domain | AAA | 2.44e-03 | 144 | 73 | 4 | SM00382 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 9.68e-09 | 18 | 60 | 5 | MM14775 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 2.86e-08 | 44 | 60 | 6 | M27812 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 6.11e-08 | 10 | 60 | 4 | MM15535 | |
| Pathway | REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.43e-07 | 12 | 60 | 4 | M27159 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 2.87e-07 | 14 | 60 | 4 | M27808 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 3.75e-07 | 67 | 60 | 6 | M26999 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 5.19e-07 | 16 | 60 | 4 | M27121 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 6.07e-07 | 39 | 60 | 5 | MM14604 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 7.85e-07 | 41 | 60 | 5 | MM15538 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.37e-06 | 20 | 60 | 4 | M27881 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 1.41e-06 | 46 | 60 | 5 | M198 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 1.58e-06 | 47 | 60 | 5 | M7946 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 2.17e-06 | 90 | 60 | 6 | M631 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 3.51e-06 | 25 | 60 | 4 | M27880 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 5.84e-06 | 61 | 60 | 5 | M39540 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 5.84e-06 | 61 | 60 | 5 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 7.41e-06 | 64 | 60 | 5 | M26953 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 1.10e-05 | 119 | 60 | 6 | M607 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 1.11e-05 | 33 | 60 | 4 | M604 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 1.52e-05 | 74 | 60 | 5 | M616 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 1.52e-05 | 74 | 60 | 5 | M160 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 1.57e-05 | 12 | 60 | 3 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 1.57e-05 | 12 | 60 | 3 | M47533 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.73e-05 | 76 | 60 | 5 | MM14573 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 2.03e-05 | 13 | 60 | 3 | M47534 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 2.50e-05 | 82 | 60 | 5 | MM15922 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 2.94e-05 | 42 | 60 | 4 | M17541 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 5.02e-05 | 48 | 60 | 4 | M611 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 5.44e-05 | 49 | 60 | 4 | M618 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 5.90e-05 | 50 | 60 | 4 | MM14796 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 7.95e-05 | 246 | 60 | 7 | M10189 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 1.06e-04 | 58 | 60 | 4 | M29616 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 1.07e-04 | 22 | 60 | 3 | MM1370 | |
| Pathway | WP_MRNA_PROCESSING | 1.12e-04 | 451 | 60 | 9 | MM15946 | |
| Pathway | PID_NOTCH_PATHWAY | 1.13e-04 | 59 | 60 | 4 | M17 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 1.22e-04 | 23 | 60 | 3 | MM14954 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.29e-04 | 61 | 60 | 4 | M27103 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 1.78e-04 | 26 | 60 | 3 | MM14793 | |
| Pathway | WP_MRNA_PROCESSING | 1.94e-04 | 126 | 60 | 5 | M39406 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 1.99e-04 | 27 | 60 | 3 | M39545 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.99e-04 | 27 | 60 | 3 | M47755 | |
| Pathway | REACTOME_FORMATION_OF_PARAXIAL_MESODERM | 2.08e-04 | 69 | 60 | 4 | M46439 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 2.23e-04 | 28 | 60 | 3 | M6177 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 3.03e-04 | 76 | 60 | 4 | MM14867 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 3.03e-04 | 76 | 60 | 4 | MM15520 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 3.17e-04 | 140 | 60 | 5 | M587 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.33e-04 | 32 | 60 | 3 | MM14924 | |
| Pathway | WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA | 3.99e-04 | 34 | 60 | 3 | M39771 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH4 | 4.05e-04 | 82 | 60 | 4 | M594 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 4.44e-04 | 84 | 60 | 4 | M1008 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 4.64e-04 | 85 | 60 | 4 | M16441 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 5.14e-04 | 37 | 60 | 3 | M27797 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 5.14e-04 | 37 | 60 | 3 | M29790 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 7.36e-04 | 96 | 60 | 4 | M27784 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 7.84e-04 | 10 | 60 | 2 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 7.84e-04 | 10 | 60 | 2 | MM1560 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 8.01e-04 | 43 | 60 | 3 | M47669 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 9.16e-04 | 45 | 60 | 3 | M39571 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 9.16e-04 | 45 | 60 | 3 | M47670 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 9.56e-04 | 11 | 60 | 2 | M15422 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 9.77e-04 | 46 | 60 | 3 | MM15971 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 1.04e-03 | 47 | 60 | 3 | M29777 | |
| Pathway | PID_HES_HEY_PATHWAY | 1.11e-03 | 48 | 60 | 3 | M288 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.14e-03 | 12 | 60 | 2 | MM1526 | |
| Pathway | REACTOME_ADIPOGENESIS | 1.22e-03 | 110 | 60 | 4 | M48259 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.35e-03 | 13 | 60 | 2 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.35e-03 | 13 | 60 | 2 | M12950 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 1.35e-03 | 13 | 60 | 2 | MM15622 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.48e-03 | 53 | 60 | 3 | MM14566 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 1.57e-03 | 14 | 60 | 2 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 1.57e-03 | 14 | 60 | 2 | M6487 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 1.59e-03 | 118 | 60 | 4 | M27316 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.69e-03 | 300 | 60 | 6 | M610 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 1.81e-03 | 15 | 60 | 2 | M27161 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.81e-03 | 15 | 60 | 2 | MM14922 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.01e-03 | 59 | 60 | 3 | M27218 | |
| Pathway | REACTOME_GASTRULATION | 2.20e-03 | 129 | 60 | 4 | M46433 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL2A1 COL4A3 NCOA3 ARID1B EGR2 MED28 TNRC6A MAML1 MAML2 ARID1A MAML3 EP300 VAV2 ZIC3 | 2.30e-03 | 1432 | 60 | 14 | M509 |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 2.61e-03 | 18 | 60 | 2 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 2.61e-03 | 18 | 60 | 2 | MM14882 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G2_CELL_CYCLE_ARREST | 2.61e-03 | 18 | 60 | 2 | M27633 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 2.65e-03 | 65 | 60 | 3 | M39682 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 2.77e-03 | 66 | 60 | 3 | M18 | |
| Pathway | BIOCARTA_LIS1_PATHWAY | 2.91e-03 | 19 | 60 | 2 | M22005 | |
| Pathway | REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS | 3.22e-03 | 20 | 60 | 2 | M497 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 3.22e-03 | 20 | 60 | 2 | M15394 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 3.22e-03 | 20 | 60 | 2 | MM15061 | |
| Pathway | REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS | 3.22e-03 | 20 | 60 | 2 | MM15469 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 4.13e-03 | 76 | 60 | 3 | M27219 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 4.26e-03 | 23 | 60 | 2 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 4.26e-03 | 23 | 60 | 2 | MM1427 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 4.55e-03 | 158 | 60 | 4 | MM14791 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 4.63e-03 | 24 | 60 | 2 | M13404 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 4.75e-03 | 258 | 60 | 5 | MM14572 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | USP34 NCOA3 ARID1B SFPQ PYGO2 TNRC6A MAML1 BCL9 ARID1A NONO MAML3 EP300 TMEM33 | 1.78e-11 | 457 | 75 | 13 | 32344865 |
| Pubmed | Interaction network of human early embryonic transcription factors. | NCOA3 ARID1B PYGO2 EGR2 ZMIZ2 GPS2 MAML1 BCL9 ARID1A EP300 SLX4 | 2.61e-10 | 351 | 75 | 11 | 38297188 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | NCOA3 ARID1B MRPL12 DYNC2H1 RBL1 ZMIZ2 PCLO MAML1 ADNP2 ARID1A EP300 | 9.77e-10 | 398 | 75 | 11 | 35016035 |
| Pubmed | NCOA3 ARID1B ARVCF MRPL12 DYNC2H1 DNAH2 MAML1 CHD6 BCL9 ARID1A DNAH7 MAML3 EP300 | 1.05e-09 | 638 | 75 | 13 | 31182584 | |
| Pubmed | 1.46e-09 | 152 | 75 | 8 | 38360978 | ||
| Pubmed | 9.63e-09 | 3 | 75 | 3 | 12386158 | ||
| Pubmed | 1.96e-08 | 14 | 75 | 4 | 9373155 | ||
| Pubmed | NCOA3 ARID1B PYGO2 MRPL12 ZMIZ2 GPS2 TNRC6A MAML1 CSTF2 CHD6 SSBP4 BCL9 ARID1A EP300 SLX4 ZIC3 | 5.25e-08 | 1429 | 75 | 16 | 35140242 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 1.31e-07 | 180 | 75 | 7 | 35198878 | |
| Pubmed | 4.55e-07 | 29 | 75 | 4 | 19279220 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 4.94e-07 | 135 | 75 | 6 | 28675934 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 5.08e-07 | 220 | 75 | 7 | 35785414 | |
| Pubmed | 5.35e-07 | 8 | 75 | 3 | 3997552 | ||
| Pubmed | 5.35e-07 | 8 | 75 | 3 | 10382266 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | USP34 POTEE USO1 DYNC2H1 TNRC6A MAML1 POTEI ARID1A NONO SLX4 | 5.47e-07 | 588 | 75 | 10 | 38580884 |
| Pubmed | NCOA3 ARID1B SFPQ MED28 ZMIZ2 GPS2 EIF4G2 MAML1 BCL9 ARID1A NONO EP300 CSTF2T | 6.26e-07 | 1103 | 75 | 13 | 34189442 | |
| Pubmed | 6.85e-07 | 32 | 75 | 4 | 31815296 | ||
| Pubmed | 8.02e-07 | 9 | 75 | 3 | 12370315 | ||
| Pubmed | 8.02e-07 | 9 | 75 | 3 | 19176441 | ||
| Pubmed | 8.55e-07 | 347 | 75 | 8 | 16033648 | ||
| Pubmed | 1.04e-06 | 83 | 75 | 5 | 28794006 | ||
| Pubmed | 1.89e-06 | 268 | 75 | 7 | 33640491 | ||
| Pubmed | Combinatorial CRISPR screen identifies fitness effects of gene paralogues. | 3.20e-06 | 186 | 75 | 6 | 33637726 | |
| Pubmed | 3.40e-06 | 418 | 75 | 8 | 34709266 | ||
| Pubmed | 3.84e-06 | 425 | 75 | 8 | 24999758 | ||
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 4.30e-06 | 15 | 75 | 3 | 16824795 | |
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 25765647 | ||
| Pubmed | A family of splice variants of CstF-64 expressed in vertebrate nervous systems. | 4.59e-06 | 2 | 75 | 2 | 19284619 | |
| Pubmed | Molecular Modelling of NONO and SFPQ Dimerization Process and RNA Recognition Mechanism. | 4.59e-06 | 2 | 75 | 2 | 35886974 | |
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 34386776 | ||
| Pubmed | Recognition of GU-rich polyadenylation regulatory elements by human CstF-64 protein. | 4.59e-06 | 2 | 75 | 2 | 12773396 | |
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 23202128 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 17029590 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 33890484 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 27924002 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 28356423 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 15590677 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 12417296 | ||
| Pubmed | Purification and characterization of a DNA-binding heterodimer of 52 and 100 kDa from HeLa cells. | 4.59e-06 | 2 | 75 | 2 | 8439294 | |
| Pubmed | ARID1B is a specific vulnerability in ARID1A-mutant cancers. | 4.59e-06 | 2 | 75 | 2 | 24562383 | |
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 14681198 | ||
| Pubmed | A primate-specific POTE-actin fusion protein plays a role in apoptosis. | 4.59e-06 | 2 | 75 | 2 | 19669888 | |
| Pubmed | The PSF.p54nrb complex is a novel Mnk substrate that binds the mRNA for tumor necrosis factor alpha. | 4.59e-06 | 2 | 75 | 2 | 17965020 | |
| Pubmed | Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis. | 4.59e-06 | 2 | 75 | 2 | 37611161 | |
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 28625977 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 32791957 | ||
| Pubmed | ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma. | 4.59e-06 | 2 | 75 | 2 | 29890703 | |
| Pubmed | AMF-1/Gps2 binds p300 and enhances its interaction with papillomavirus E2 proteins. | 4.59e-06 | 2 | 75 | 2 | 10846067 | |
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 25605962 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 24788099 | ||
| Pubmed | PSF/p54(nrb) stimulates "jumping" of DNA topoisomerase I between separate DNA helices. | 4.59e-06 | 2 | 75 | 2 | 10858305 | |
| Pubmed | Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers. | 4.59e-06 | 2 | 75 | 2 | 28967863 | |
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 12944487 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 16207706 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 33052929 | ||
| Pubmed | Deltex1 is a target of the transcription factor NFAT that promotes T cell anergy. | 4.59e-06 | 2 | 75 | 2 | 19592273 | |
| Pubmed | Overlapping and distinct functions of CstF64 and CstF64Ï„ in mammalian mRNA 3' processing. | 4.59e-06 | 2 | 75 | 2 | 24149845 | |
| Pubmed | Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas. | 4.59e-06 | 2 | 75 | 2 | 27562491 | |
| Pubmed | Mastermind-like 1 (MamL1) and mastermind-like 3 (MamL3) are essential for Notch signaling in vivo. | 5.29e-06 | 16 | 75 | 3 | 22069191 | |
| Pubmed | 6.13e-06 | 453 | 75 | 8 | 29656893 | ||
| Pubmed | 7.68e-06 | 18 | 75 | 3 | 27984743 | ||
| Pubmed | 9.10e-06 | 19 | 75 | 3 | 15689378 | ||
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 1.01e-05 | 62 | 75 | 4 | 28344315 | |
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 33432679 | ||
| Pubmed | Pygopus residues required for its binding to Legless are critical for transcription and development. | 1.37e-05 | 3 | 75 | 2 | 14612447 | |
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 21647563 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 15145939 | ||
| Pubmed | P54nrb forms a heterodimer with PSP1 that localizes to paraspeckles in an RNA-dependent manner. | 1.37e-05 | 3 | 75 | 2 | 16148043 | |
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 34044070 | ||
| Pubmed | Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes. | 1.37e-05 | 3 | 75 | 2 | 26716708 | |
| Pubmed | hnRNP M interacts with PSF and p54(nrb) and co-localizes within defined nuclear structures. | 1.37e-05 | 3 | 75 | 2 | 19874820 | |
| Pubmed | Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex. | 1.37e-05 | 3 | 75 | 2 | 12050117 | |
| Pubmed | Proteomic identification of a PSF/p54nrb heterodimer as RNF43 oncoprotein-interacting proteins. | 1.37e-05 | 3 | 75 | 2 | 18655028 | |
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 16641145 | ||
| Pubmed | Proteomic identification of PSF and p54(nrb) as TopBP1-interacting proteins. | 1.37e-05 | 3 | 75 | 2 | 22213094 | |
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 15790595 | ||
| Pubmed | The MN1 oncoprotein synergizes with coactivators RAC3 and p300 in RAR-RXR-mediated transcription. | 1.37e-05 | 3 | 75 | 2 | 12569362 | |
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 30445466 | ||
| Pubmed | Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators. | 1.37e-05 | 3 | 75 | 2 | 11823864 | |
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 25326457 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 17639083 | ||
| Pubmed | COL4A6 is dispensable for autosomal recessive Alport syndrome. | 1.37e-05 | 3 | 75 | 2 | 27377778 | |
| Pubmed | Evolution and expression of chimeric POTE-actin genes in the human genome. | 1.37e-05 | 3 | 75 | 2 | 17101985 | |
| Pubmed | AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. | 1.37e-05 | 3 | 75 | 2 | 10866661 | |
| Pubmed | Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome. | 1.37e-05 | 3 | 75 | 2 | 22426308 | |
| Pubmed | Involvement of Matrin 3 and SFPQ/NONO in the DNA damage response. | 1.37e-05 | 3 | 75 | 2 | 20421735 | |
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 24382590 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 12539049 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 9393982 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 20637214 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 11525732 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 34512623 | ||
| Pubmed | 1.65e-05 | 23 | 75 | 3 | 9225980 | ||
| Pubmed | 1.89e-05 | 24 | 75 | 3 | 25344368 | ||
| Pubmed | 2.08e-05 | 153 | 75 | 5 | 28225217 | ||
| Pubmed | 2.08e-05 | 153 | 75 | 5 | 25037231 | ||
| Pubmed | The candidate splicing factor Sfswap regulates growth and patterning of inner ear sensory organs. | 2.42e-05 | 26 | 75 | 3 | 24391519 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 2.72e-05 | 271 | 75 | 6 | 32433965 | |
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 16227615 | ||
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 33589584 | ||
| Interaction | PAX7 interactions | 3.18e-11 | 124 | 75 | 10 | int:PAX7 | |
| Interaction | TLE3 interactions | NCOA3 ARID1B PYGO2 EGR2 ZMIZ2 GPS2 TNRC6A MAML1 CSTF2 CHD6 SSBP4 BCL9 ARID1A EP300 | 9.74e-11 | 376 | 75 | 14 | int:TLE3 |
| Interaction | EGR2 interactions | 7.65e-10 | 171 | 75 | 10 | int:EGR2 | |
| Interaction | PAX9 interactions | 1.28e-09 | 130 | 75 | 9 | int:PAX9 | |
| Interaction | CRX interactions | SMAP1 NCOA3 ARID1B PYGO2 SMUG1 ZMIZ2 MAML1 BCL9 ARID1A PICALM EP300 | 2.47e-09 | 254 | 75 | 11 | int:CRX |
| Interaction | NUP35 interactions | USP34 NCOA3 ARID1B SFPQ PYGO2 TNRC6A MAML1 BCL9 ARID1A NONO MAML3 EP300 TMEM33 | 5.11e-09 | 424 | 75 | 13 | int:NUP35 |
| Interaction | ETV4 interactions | 6.66e-09 | 69 | 75 | 7 | int:ETV4 | |
| Interaction | PAX8 interactions | 8.15e-09 | 111 | 75 | 8 | int:PAX8 | |
| Interaction | ERG interactions | 9.95e-09 | 223 | 75 | 10 | int:ERG | |
| Interaction | SOX7 interactions | 2.26e-08 | 82 | 75 | 7 | int:SOX7 | |
| Interaction | SOX10 interactions | 5.05e-08 | 92 | 75 | 7 | int:SOX10 | |
| Interaction | TLX3 interactions | 1.22e-07 | 291 | 75 | 10 | int:TLX3 | |
| Interaction | TBR1 interactions | 2.09e-07 | 113 | 75 | 7 | int:TBR1 | |
| Interaction | TBXT interactions | 2.51e-07 | 116 | 75 | 7 | int:TBXT | |
| Interaction | MAML1 interactions | 3.03e-07 | 73 | 75 | 6 | int:MAML1 | |
| Interaction | NFIA interactions | 4.89e-07 | 188 | 75 | 8 | int:NFIA | |
| Interaction | IRF4 interactions | 7.51e-07 | 85 | 75 | 6 | int:IRF4 | |
| Interaction | C1QTNF1 interactions | 8.47e-07 | 47 | 75 | 5 | int:C1QTNF1 | |
| Interaction | SOX15 interactions | 9.43e-07 | 141 | 75 | 7 | int:SOX15 | |
| Interaction | FOXI1 interactions | 1.20e-06 | 92 | 75 | 6 | int:FOXI1 | |
| Interaction | SS18L1 interactions | 1.74e-06 | 98 | 75 | 6 | int:SS18L1 | |
| Interaction | SP7 interactions | 1.89e-06 | 304 | 75 | 9 | int:SP7 | |
| Interaction | TLE6 interactions | 2.11e-06 | 25 | 75 | 4 | int:TLE6 | |
| Interaction | NR3C1 interactions | NCOA3 ARID1B SFPQ ARVCF MRPL12 DYNC2H1 DNAH2 MAML1 CHD6 BCL9 ARID1A NONO DNAH7 MAML3 EP300 | 2.47e-06 | 974 | 75 | 15 | int:NR3C1 |
| Interaction | EYA4 interactions | 3.35e-06 | 243 | 75 | 8 | int:EYA4 | |
| Interaction | TLX1 interactions | 3.99e-06 | 175 | 75 | 7 | int:TLX1 | |
| Interaction | GCM1 interactions | 5.41e-06 | 68 | 75 | 5 | int:GCM1 | |
| Interaction | HNF1B interactions | 6.85e-06 | 190 | 75 | 7 | int:HNF1B | |
| Interaction | E2F5 interactions | 9.52e-06 | 36 | 75 | 4 | int:E2F5 | |
| Interaction | FEV interactions | 1.05e-05 | 203 | 75 | 7 | int:FEV | |
| Interaction | CREBBP interactions | NCOA3 ARID1B PYGO2 EGR2 EIF4G2 MAML1 MAML2 ARID1A NONO EP300 SLX4 | 1.27e-05 | 599 | 75 | 11 | int:CREBBP |
| Interaction | AR interactions | USP34 NCOA3 ARID1B SFPQ PYGO2 RBL1 ZMIZ2 GPS2 MAML1 BCL9 ARID1A NONO EP300 VAV2 | 1.51e-05 | 992 | 75 | 14 | int:AR |
| Interaction | TP53BP1 interactions | 2.73e-05 | 533 | 75 | 10 | int:TP53BP1 | |
| Interaction | SOX17 interactions | 2.78e-05 | 95 | 75 | 5 | int:SOX17 | |
| Interaction | BCL9L interactions | 3.04e-05 | 48 | 75 | 4 | int:BCL9L | |
| Interaction | SOX9 interactions | 3.08e-05 | 97 | 75 | 5 | int:SOX9 | |
| Interaction | DTX2 interactions | 3.09e-05 | 330 | 75 | 8 | int:DTX2 | |
| Interaction | MAML2 interactions | 3.24e-05 | 17 | 75 | 3 | int:MAML2 | |
| Interaction | LHX4 interactions | 3.59e-05 | 166 | 75 | 6 | int:LHX4 | |
| Interaction | LHX1 interactions | 4.11e-05 | 103 | 75 | 5 | int:LHX1 | |
| Interaction | SMARCA4 interactions | 5.32e-05 | 462 | 75 | 9 | int:SMARCA4 | |
| Interaction | ALG13 interactions | 6.19e-05 | 183 | 75 | 6 | int:ALG13 | |
| Interaction | NOTCH4 interactions | 6.27e-05 | 21 | 75 | 3 | int:NOTCH4 | |
| Interaction | RARG interactions | 6.45e-05 | 58 | 75 | 4 | int:RARG | |
| Interaction | CPA5 interactions | 7.25e-05 | 22 | 75 | 3 | int:CPA5 | |
| Interaction | KLF5 interactions | 8.79e-05 | 195 | 75 | 6 | int:KLF5 | |
| Interaction | SMARCC1 interactions | 8.95e-05 | 384 | 75 | 8 | int:SMARCC1 | |
| Interaction | GATA2 interactions | 9.83e-05 | 199 | 75 | 6 | int:GATA2 | |
| Interaction | MMP9 interactions | 1.14e-04 | 67 | 75 | 4 | int:MMP9 | |
| Interaction | EWSR1 interactions | NCOA3 SFPQ POTEF PCLO MAML1 CSTF2 BCL9 ARID1A NONO PICALM EP300 CSTF2T | 1.21e-04 | 906 | 75 | 12 | int:EWSR1 |
| Interaction | COL11A1 interactions | 1.69e-04 | 29 | 75 | 3 | int:COL11A1 | |
| Interaction | CEBPA interactions | NCOA3 ARID1B SFPQ RBL1 MED28 ZMIZ2 GPS2 EIF4G2 MAML1 BCL9 ARID1A NONO EP300 CSTF2T | 1.77e-04 | 1245 | 75 | 14 | int:CEBPA |
| Interaction | SS18L2 interactions | 1.85e-04 | 76 | 75 | 4 | int:SS18L2 | |
| Interaction | NFIB interactions | 1.88e-04 | 142 | 75 | 5 | int:NFIB | |
| Interaction | TLX2 interactions | 1.88e-04 | 142 | 75 | 5 | int:TLX2 | |
| Interaction | CYP1A1 interactions | 1.95e-04 | 77 | 75 | 4 | int:CYP1A1 | |
| Interaction | NONO interactions | 1.97e-04 | 549 | 75 | 9 | int:NONO | |
| Interaction | PTP4A3 interactions | 2.74e-04 | 154 | 75 | 5 | int:PTP4A3 | |
| Interaction | PAX2 interactions | 2.85e-04 | 85 | 75 | 4 | int:PAX2 | |
| Interaction | LYZL2 interactions | 2.85e-04 | 85 | 75 | 4 | int:LYZL2 | |
| Interaction | DTX1 interactions | 2.97e-04 | 35 | 75 | 3 | int:DTX1 | |
| Interaction | BCL9 interactions | 2.98e-04 | 86 | 75 | 4 | int:BCL9 | |
| Interaction | SMARCA2 interactions | 3.02e-04 | 346 | 75 | 7 | int:SMARCA2 | |
| Interaction | GSC interactions | 3.12e-04 | 87 | 75 | 4 | int:GSC | |
| Interaction | MMP2 interactions | 3.12e-04 | 87 | 75 | 4 | int:MMP2 | |
| Interaction | HOXB2 interactions | 3.24e-04 | 36 | 75 | 3 | int:HOXB2 | |
| Interaction | KLF4 interactions | 3.27e-04 | 160 | 75 | 5 | int:KLF4 | |
| Interaction | PIAS1 interactions | 3.41e-04 | 353 | 75 | 7 | int:PIAS1 | |
| Interaction | C1QTNF9 interactions | 3.51e-04 | 37 | 75 | 3 | int:C1QTNF9 | |
| Interaction | SLC25A41 interactions | 3.55e-04 | 90 | 75 | 4 | int:SLC25A41 | |
| Interaction | PITX3 interactions | 3.77e-04 | 8 | 75 | 2 | int:PITX3 | |
| Interaction | SFTPA2 interactions | 3.80e-04 | 38 | 75 | 3 | int:SFTPA2 | |
| Interaction | PAX6 interactions | 4.23e-04 | 366 | 75 | 7 | int:PAX6 | |
| Interaction | ISL2 interactions | 4.77e-04 | 41 | 75 | 3 | int:ISL2 | |
| Interaction | COL21A1 interactions | 4.84e-04 | 9 | 75 | 2 | int:COL21A1 | |
| Interaction | NPAS2 interactions | 5.12e-04 | 42 | 75 | 3 | int:NPAS2 | |
| Interaction | COL8A2 interactions | 5.12e-04 | 42 | 75 | 3 | int:COL8A2 | |
| Interaction | DCN interactions | 5.49e-04 | 43 | 75 | 3 | int:DCN | |
| Interaction | PIN1 interactions | 5.54e-04 | 383 | 75 | 7 | int:PIN1 | |
| Interaction | HNF4A interactions | 5.60e-04 | 275 | 75 | 6 | int:HNF4A | |
| Interaction | HLA-DQB2 interactions | 6.03e-04 | 10 | 75 | 2 | int:HLA-DQB2 | |
| Interaction | PAPOLB interactions | 6.03e-04 | 10 | 75 | 2 | int:PAPOLB | |
| Interaction | MESP1 interactions | 6.03e-04 | 10 | 75 | 2 | int:MESP1 | |
| Interaction | CD93 interactions | 6.28e-04 | 45 | 75 | 3 | int:CD93 | |
| Interaction | LHX3 interactions | 6.34e-04 | 185 | 75 | 5 | int:LHX3 | |
| Interaction | SSBP2 interactions | 6.37e-04 | 105 | 75 | 4 | int:SSBP2 | |
| Interaction | GATA3 interactions | 6.65e-04 | 187 | 75 | 5 | int:GATA3 | |
| Interaction | RARB interactions | 6.70e-04 | 46 | 75 | 3 | int:RARB | |
| Interaction | SOX2 interactions | USP34 NCOA3 ARID1B PYGO2 MRPL12 ZMIZ2 GPS2 TNRC6A MAML1 CHD6 BCL9 ARID1A PICALM EP300 | 6.80e-04 | 1422 | 75 | 14 | int:SOX2 |
| Interaction | SMARCD3 interactions | 6.83e-04 | 107 | 75 | 4 | int:SMARCD3 | |
| Interaction | ADAR interactions | 6.87e-04 | 286 | 75 | 6 | int:ADAR | |
| Interaction | ACTL6A interactions | 7.26e-04 | 289 | 75 | 6 | int:ACTL6A | |
| Interaction | ATPSCKMT interactions | 7.35e-04 | 11 | 75 | 2 | int:ATPSCKMT | |
| Interaction | KLF15 interactions | 7.39e-04 | 290 | 75 | 6 | int:KLF15 | |
| Interaction | PYGO2 interactions | 7.59e-04 | 48 | 75 | 3 | int:PYGO2 | |
| Interaction | PLOD1 interactions | 7.66e-04 | 292 | 75 | 6 | int:PLOD1 | |
| Interaction | MYOD1 interactions | 7.85e-04 | 194 | 75 | 5 | int:MYOD1 | |
| Interaction | LAIR2 interactions | 8.07e-04 | 49 | 75 | 3 | int:LAIR2 | |
| Interaction | MTSS2 interactions | 8.07e-04 | 49 | 75 | 3 | int:MTSS2 | |
| Interaction | ACTG2 interactions | 8.07e-04 | 49 | 75 | 3 | int:ACTG2 | |
| Cytoband | 2q21.1 | 1.21e-04 | 58 | 75 | 3 | 2q21.1 | |
| Cytoband | 9q34.1 | 4.42e-04 | 19 | 75 | 2 | 9q34.1 | |
| Cytoband | 11q12 | 5.42e-04 | 21 | 75 | 2 | 11q12 | |
| Cytoband | 20q12 | 7.10e-04 | 24 | 75 | 2 | 20q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q21 | 1.98e-03 | 151 | 75 | 3 | chr2q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p12 | 2.86e-03 | 172 | 75 | 3 | chr16p12 | |
| GeneFamily | Collagens | 4.06e-09 | 46 | 53 | 6 | 490 | |
| GeneFamily | RNA binding motif containing | 2.78e-06 | 213 | 53 | 7 | 725 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 6.66e-06 | 13 | 53 | 3 | 685 | |
| GeneFamily | Dyneins, axonemal | 1.57e-05 | 17 | 53 | 3 | 536 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 5.23e-05 | 25 | 53 | 3 | 775 | |
| GeneFamily | AT-rich interaction domain containing | 8.64e-04 | 15 | 53 | 2 | 418 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.11e-03 | 17 | 53 | 2 | 486 | |
| Coexpression | NABA_COLLAGENS | 2.67e-09 | 44 | 74 | 6 | M3005 | |
| Coexpression | NABA_COLLAGENS | 1.38e-07 | 43 | 74 | 5 | MM17060 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP | 2.20e-05 | 200 | 74 | 6 | M5781 | |
| Coexpression | LAKE_ADULT_KIDNEY_C13_THICK_ASCENDING_LIMB | 3.53e-05 | 131 | 74 | 5 | M39232 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 4.42e-05 | 457 | 74 | 8 | M1613 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 5.39e-05 | 470 | 74 | 8 | MM1053 | |
| Coexpression | YANAGIHARA_ESX1_TARGETS | 7.49e-05 | 29 | 74 | 3 | M1538 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 7.49e-05 | 29 | 74 | 3 | MM17055 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.58e-08 | 199 | 75 | 7 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.56e-05 | 186 | 75 | 5 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.56e-05 | 186 | 75 | 5 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.87e-05 | 193 | 75 | 5 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type. | 2.01e-05 | 196 | 75 | 5 | 1e9ccbd5be7839a74108f0cd07a6d2d736bc7f1b | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.06e-05 | 197 | 75 | 5 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids|saliva / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.06e-05 | 197 | 75 | 5 | c747d05bb032abf8dad46ff6f4d1951bbe64b3b4 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 2.11e-05 | 198 | 75 | 5 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.16e-05 | 199 | 75 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | facs-Aorta-Heart-18m-Mesenchymal-fibrocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 156 | 75 | 4 | 5b56217336771baf57d791efcb4e206c6aea83b1 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-04 | 157 | 75 | 4 | 74038192f016f95f80e0189035ee8ccc22ceb1b8 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-04 | 157 | 75 | 4 | 982e6ea78c7dabdb7c07c4a5fb2425d5e45b5b94 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Glioblastoma-Primary_GBM-11|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.64e-04 | 63 | 75 | 3 | d7dc1356a60cb527fe668328d5375f352239d911 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-04 | 163 | 75 | 4 | 132aece9c79499b4bb3c2bde68d3d7202e1d8772 | |
| ToppCell | severe-CD4+_T_naive|severe / disease stage, cell group and cell class | 1.81e-04 | 167 | 75 | 4 | 02a8215fca59c357c1cdaa5738849eacf98c0bcc | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.90e-04 | 169 | 75 | 4 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.98e-04 | 171 | 75 | 4 | b7cddb8f726a43fb8a37f3e67a3f722e2178fd7a | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Alveolar_Mac|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.07e-04 | 173 | 75 | 4 | 4efa0878ed1ede8fa5d6c191a76d4f70558ba761 | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 176 | 75 | 4 | 3494ffa8555e6edf4b1250e10434bae9b73ec845 | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 176 | 75 | 4 | d43f6b7828b98e1dab7b726a5f99499d65a7db80 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 2.21e-04 | 176 | 75 | 4 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.26e-04 | 177 | 75 | 4 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-04 | 177 | 75 | 4 | 26bad614560609d318bfc9c235a698bca4e1c22c | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.26e-04 | 177 | 75 | 4 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 179 | 75 | 4 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | Control-Myeloid-Dendritic_cells|Control / group, cell type (main and fine annotations) | 2.41e-04 | 180 | 75 | 4 | 25ad95c3c30e3b82abe93bd77ba003f5c2241f7c | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-basal_late|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.41e-04 | 180 | 75 | 4 | 255097d8eb244a32eb2ecd0e7e48e1a20bafb5cd | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.41e-04 | 180 | 75 | 4 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.41e-04 | 180 | 75 | 4 | 2ccc77d769d3ffd77ab3af45e4f192785b6db79c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.46e-04 | 181 | 75 | 4 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-04 | 182 | 75 | 4 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-04 | 182 | 75 | 4 | d82f59a3f930a840dde27dc6ab024f227a26d446 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.57e-04 | 183 | 75 | 4 | 82fe14fc7039415de41bdfd615a1380bed99f560 | |
| ToppCell | Control-APC-like-Dendritic_cells|Control / group, cell type (main and fine annotations) | 2.57e-04 | 183 | 75 | 4 | 8f9c8e2436f18ea7c265b08e4e149e19cb513a16 | |
| ToppCell | Control-APC-like|Control / group, cell type (main and fine annotations) | 2.57e-04 | 183 | 75 | 4 | c313ac72cc9fa1583456d452393f61f0a4ca33a8 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-04 | 183 | 75 | 4 | b5ede5a0048c585b73c00e88aeddbcaf669347b1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.57e-04 | 183 | 75 | 4 | f2ef110bf29b1a8276ef216238363e542db262c1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-04 | 184 | 75 | 4 | d33de57876817050b294f2ecb0a4eb0634cfa7f0 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic-DC1|bone_marrow / Manually curated celltypes from each tissue | 2.62e-04 | 184 | 75 | 4 | ee295f6fa898da53883e1358b17f2c2dd177e9a7 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-04 | 185 | 75 | 4 | a0a629e5d2b65f670ea907bd3f5e3caf17687d8f | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.68e-04 | 185 | 75 | 4 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.68e-04 | 185 | 75 | 4 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-04 | 185 | 75 | 4 | d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.68e-04 | 185 | 75 | 4 | b4af9ae4c358b48357cb135b740266e1652d886a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.73e-04 | 186 | 75 | 4 | 77592a6397b44b2b59a4fc39d7224dd95343efe6 | |
| ToppCell | BL-critical-LOC-Lymphoid-B_cell|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.73e-04 | 186 | 75 | 4 | 27d4c38b180e4ce2bf3e7c4ad3db3a2ffca05ca8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.79e-04 | 187 | 75 | 4 | d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.85e-04 | 188 | 75 | 4 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.85e-04 | 188 | 75 | 4 | ee572246e0c2f41bdbc29a03edc67b831af95c09 | |
| ToppCell | facs-MAT-Fat-3m|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-04 | 188 | 75 | 4 | 7da9750255efbc5cf9aed7e3105a337fac63b9f0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-04 | 189 | 75 | 4 | 3a295c215b5c18e7c673f92b7af5be523421682c | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-04 | 189 | 75 | 4 | 6dd4ec5ce4beb856f0d2d1654e3c4676d1d63736 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.90e-04 | 189 | 75 | 4 | 57ab947b81dbd9d3e896be89e28c4a62cf720837 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.90e-04 | 189 | 75 | 4 | ebc16b8eab84167d74446783d7e802acedc6b9c6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-04 | 189 | 75 | 4 | fc88c51ace7d883c01617f3f9b5fab70cc91cc09 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.90e-04 | 189 | 75 | 4 | 2b53dae0e6e85b7139f8a9872fbebb3705b2f1bf | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-04 | 189 | 75 | 4 | 562f8bf5a7d38afb4a8f2415d617d5f79cfb7e3f | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-04 | 189 | 75 | 4 | 3ae479ec7e00c57127cbe51a398329b10ca9848c | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-04 | 189 | 75 | 4 | 875df61ee48baa5142ba4d2427bdec1c53e5a828 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-04 | 189 | 75 | 4 | 532aaf02b364c5c4f58a2021c7c21d86df3875c9 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-04 | 189 | 75 | 4 | 270dd4a0fc5260288fe6829837942c78b40ecec4 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-04 | 189 | 75 | 4 | 97ef5215d841ff366a3e3682cd9bd04100cbfde0 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.96e-04 | 190 | 75 | 4 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.96e-04 | 190 | 75 | 4 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | facs-GAT-Fat-3m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 190 | 75 | 4 | 1d92be1b41cff59e834a9d28868f554bd1f3e471 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_2|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.96e-04 | 190 | 75 | 4 | 6514f00d222eef08c282face7f177259bca62f0e | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Radial_glial-RGCs_early_2|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 3.02e-04 | 191 | 75 | 4 | 06107849463a1ccb78a5ccd3ae31619ef6bedda3 | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.02e-04 | 191 | 75 | 4 | 3b59bfc6c106ae8a3fbcd4a74bd128c485724921 | |
| ToppCell | Control-Myeloid|Control / group, cell type (main and fine annotations) | 3.02e-04 | 191 | 75 | 4 | 9c4acc5f3c2f9c0c5520863bb22f391774372347 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.02e-04 | 191 | 75 | 4 | 054fa0493b00149313c243d39cf39a264044f074 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 3.02e-04 | 191 | 75 | 4 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.08e-04 | 192 | 75 | 4 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.08e-04 | 192 | 75 | 4 | f053b89bfd6048c227667ff01c38df7c51d8a496 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.08e-04 | 192 | 75 | 4 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.08e-04 | 192 | 75 | 4 | ab7420aeb22620d85c60b33cf372e5168e538cd4 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 3.08e-04 | 192 | 75 | 4 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.08e-04 | 192 | 75 | 4 | 2510f22197502f60fd266b7f42eff040f25b8ae7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.08e-04 | 192 | 75 | 4 | e8e316f396834bcd34843e56e1d86f310fd6aada | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.14e-04 | 193 | 75 | 4 | 7cc10e8b51091869d46e462f3214999e7b5348b1 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.14e-04 | 193 | 75 | 4 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 3.14e-04 | 193 | 75 | 4 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.21e-04 | 194 | 75 | 4 | 2b61023a602d336ed0de174e9141046173db34e6 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.21e-04 | 194 | 75 | 4 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 194 | 75 | 4 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.21e-04 | 194 | 75 | 4 | 5022c85ad3b137dae4b9ff11f9c23bb3bf4c0f5a | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.21e-04 | 194 | 75 | 4 | e237384b02be460d44eeada3026a5691c66f6fc1 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.21e-04 | 194 | 75 | 4 | 2b5eee7c3e52b63cce94205d18133c7704329c02 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.21e-04 | 194 | 75 | 4 | f2486b19ac52a48d19f80b38a5536bee3dad745b | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.21e-04 | 194 | 75 | 4 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.21e-04 | 194 | 75 | 4 | 0bc83ae79873a5e473e6e1e3111924cd003986a1 | |
| ToppCell | Macrophages-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 3.21e-04 | 194 | 75 | 4 | 543b856b0fd883550c8f14baeae08fb9bf1a7768 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.21e-04 | 194 | 75 | 4 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.21e-04 | 194 | 75 | 4 | 8c37bedb23285735ff3828db3889897fada8c95d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.21e-04 | 194 | 75 | 4 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.21e-04 | 194 | 75 | 4 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.27e-04 | 195 | 75 | 4 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.27e-04 | 195 | 75 | 4 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | Mild/Remission-B_naive-8|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.27e-04 | 195 | 75 | 4 | 0a3221e4d1fa31a35868bdda0f0cc873c233b407 | |
| ToppCell | Control-Myeloid-ncMonocyte|Control / Disease state, Lineage and Cell class | 3.27e-04 | 195 | 75 | 4 | fcb05948e7480dc53f06f3fc9b9c3fc129874edd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.27e-04 | 195 | 75 | 4 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| Drug | GK-101 | 1.88e-09 | 36 | 75 | 6 | CID000161853 | |
| Drug | Madecassol | 8.79e-09 | 46 | 75 | 6 | CID000108062 | |
| Drug | d-indobufen | 1.48e-08 | 50 | 75 | 6 | CID000044562 | |
| Drug | ridogrel | 1.88e-08 | 52 | 75 | 6 | CID005362391 | |
| Drug | NSC49633 | 2.12e-08 | 53 | 75 | 6 | CID000023340 | |
| Drug | AC1LAKND | 5.53e-08 | 62 | 75 | 6 | CID000470146 | |
| Drug | BAPN | 1.26e-07 | 71 | 75 | 6 | CID000001647 | |
| Drug | malotilate | 1.26e-07 | 71 | 75 | 6 | CID000004006 | |
| Drug | AC1NMZ1B | 1.75e-07 | 75 | 75 | 6 | CID005034185 | |
| Drug | strontium ranelate | 2.05e-07 | 77 | 75 | 6 | CID006918182 | |
| Drug | halofuginone lactate | 3.71e-07 | 85 | 75 | 6 | CID000062891 | |
| Drug | 4-hydroxyproline | 5.57e-07 | 91 | 75 | 6 | CID000000825 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 1.07e-06 | 162 | 75 | 7 | CID000072363 | |
| Drug | ticlopidine | 1.16e-06 | 103 | 75 | 6 | CID000005472 | |
| Drug | khellin | 1.54e-06 | 171 | 75 | 7 | CID000003828 | |
| Drug | hydroxylysine | 1.61e-06 | 109 | 75 | 6 | CID000001029 | |
| Drug | AC1L1C2F | 1.70e-06 | 110 | 75 | 6 | CID000001711 | |
| Drug | PPACK | 1.99e-06 | 113 | 75 | 6 | CID003036757 | |
| Drug | AC1L9732 | 2.10e-06 | 114 | 75 | 6 | CID000439300 | |
| Drug | Tranilast sodium | 2.21e-06 | 115 | 75 | 6 | CID000005527 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 3.00e-06 | 189 | 75 | 7 | CID000001413 | |
| Drug | Selara | 3.59e-06 | 125 | 75 | 6 | CID000150310 | |
| Drug | DMSe | 4.91e-06 | 132 | 75 | 6 | CID000020796 | |
| Drug | pirfenidone | 6.35e-06 | 138 | 75 | 6 | CID000040632 | |
| Drug | DL-penicillamine | 6.62e-06 | 139 | 75 | 6 | CID000004727 | |
| Drug | PCR 4099 | 6.62e-06 | 139 | 75 | 6 | CID000002806 | |
| Drug | candesartan cilexetil | 8.44e-06 | 145 | 75 | 6 | CID000002540 | |
| Drug | AC1L1DD6 | 2.79e-05 | 179 | 75 | 6 | CID000002299 | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 3.67e-05 | 188 | 75 | 6 | 6735_DN | |
| Drug | foscarnet | 3.90e-05 | 190 | 75 | 6 | CID000003414 | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; HL60; HT_HG-U133A | 3.90e-05 | 190 | 75 | 6 | 6199_UP | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 10uM; PC3; HT_HG-U133A | 4.01e-05 | 191 | 75 | 6 | 3823_DN | |
| Drug | Atractyloside potassium salt [102130-43-8]; Down 200; 5uM; PC3; HT_HG-U133A | 4.50e-05 | 195 | 75 | 6 | 3695_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A | 4.50e-05 | 195 | 75 | 6 | 1665_DN | |
| Drug | Ketoprofen [22071-15-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 4.77e-05 | 197 | 75 | 6 | 4751_DN | |
| Drug | AG-013608 [351320-38-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 4.90e-05 | 198 | 75 | 6 | 5904_DN | |
| Drug | Pirenperone [ 75444-65-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 4.90e-05 | 198 | 75 | 6 | 5639_UP | |
| Drug | Doxylamine succinate [562-10-7]; Up 200; 10.2uM; PC3; HG-U133A | 5.04e-05 | 199 | 75 | 6 | 1893_UP | |
| Drug | Y-27632 | 1.06e-04 | 444 | 75 | 8 | CID000005711 | |
| Drug | AC1Q6PCP | 1.12e-04 | 230 | 75 | 6 | CID000005267 | |
| Drug | AC1MHEDL | 1.29e-04 | 78 | 75 | 4 | CID003002890 | |
| Drug | BPAT-143 | 1.59e-04 | 6 | 75 | 2 | CID000146249 | |
| Drug | prostacyclin sodium salt | 1.76e-04 | 250 | 75 | 6 | CID000000159 | |
| Drug | Asbestos, Crocidolite | COL4A6 NCOA3 ARID1B SFPQ EGR2 DYNC2H1 GPS2 EHF DAB2 MAML1 MAML2 ARID1A MAML3 | 1.90e-04 | 1241 | 75 | 13 | ctd:D017638 |
| Disease | diastolic blood pressure, systolic blood pressure | 3.23e-05 | 670 | 71 | 9 | EFO_0006335, EFO_0006336 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 5.68e-05 | 5 | 71 | 2 | C3281201 | |
| Disease | MiT family translocation renal cell carcinoma | 1.19e-04 | 7 | 71 | 2 | C4518356 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 1.33e-04 | 41 | 71 | 3 | C0496956 | |
| Disease | Carcinoma, Transitional Cell | 1.33e-04 | 41 | 71 | 3 | C0007138 | |
| Disease | Breast adenocarcinoma | 1.33e-04 | 41 | 71 | 3 | C0858252 | |
| Disease | Neuroblastoma | 2.01e-04 | 47 | 71 | 3 | C0027819 | |
| Disease | myopathy (implicated_via_orthology) | 2.14e-04 | 48 | 71 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | neuroblastoma (is_implicated_in) | 2.54e-04 | 10 | 71 | 2 | DOID:769 (is_implicated_in) | |
| Disease | Methionine sulfoxide measurement | 3.71e-04 | 12 | 71 | 2 | EFO_0021650 | |
| Disease | collagen disease (implicated_via_orthology) | 3.71e-04 | 12 | 71 | 2 | DOID:854 (implicated_via_orthology) | |
| Disease | Coffin-Siris syndrome | 4.38e-04 | 13 | 71 | 2 | C0265338 | |
| Disease | T-Cell Lymphoma | 6.70e-04 | 16 | 71 | 2 | C0079772 | |
| Disease | household income | 8.39e-04 | 304 | 71 | 5 | EFO_0009695 | |
| Disease | acute lymphoblastic leukemia, response to antineoplastic agent | 9.51e-04 | 19 | 71 | 2 | EFO_0000220, GO_0097327 | |
| Disease | smoking cessation | 1.13e-03 | 325 | 71 | 5 | EFO_0004319 | |
| Disease | Adenoid Cystic Carcinoma | 1.83e-03 | 100 | 71 | 3 | C0010606 | |
| Disease | gastroesophageal reflux disease | 1.88e-03 | 101 | 71 | 3 | EFO_0003948 | |
| Disease | Breast Carcinoma | 1.88e-03 | 538 | 71 | 6 | C0678222 | |
| Disease | susceptibility to rheumatic fever measurement | 2.07e-03 | 28 | 71 | 2 | EFO_0008416 | |
| Disease | Bilateral Wilms Tumor | 2.22e-03 | 29 | 71 | 2 | C2930471 | |
| Disease | intellectual disability (is_implicated_in) | 2.38e-03 | 30 | 71 | 2 | DOID:1059 (is_implicated_in) | |
| Disease | Ciliopathies | 2.40e-03 | 110 | 71 | 3 | C4277690 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PNLNMGVGGPGQVMA | 91 | Q09472 | |
| AGMNPGMLAAGNGQG | 171 | Q09472 | |
| GGGMPNMGQQPAPQV | 296 | Q09472 | |
| QGPFGMPGMPGQSMR | 1451 | Q14031 | |
| QPGMVSGGMGSGQPL | 46 | O00192 | |
| GEPGLRGIPGSMGNM | 1006 | Q01955 | |
| PGLPGVPGSMGDMVN | 1421 | Q07092 | |
| GKMGATGPMGQQGIP | 1546 | Q07092 | |
| GNFSIQVPGMQMGQP | 11 | P28676 | |
| MQGSPGGHNRPGTLM | 131 | Q13227 | |
| QGRTPGAMAGMQYPQ | 646 | Q8NFD5 | |
| GQIQTHGIPPQMMGG | 1506 | Q8NFD5 | |
| GAPPLMQASMQGGVP | 241 | P33240 | |
| SLAPGGGMQAQVGMP | 271 | P33240 | |
| GGMQAQVGMPGSGPV | 276 | P33240 | |
| QVGMPGSGPVSMERG | 281 | P33240 | |
| GVGMSGLNPGPAVPM | 26 | Q96J87 | |
| SGVLPAGQMTPAGQM | 446 | Q6IQ32 | |
| AGGAQLGVMQGPMGP | 191 | P02458 | |
| GPFDQMNGVAGDGMI | 46 | P11161 | |
| GINPMGAGGQMHGQP | 831 | O14497 | |
| TGPPYGQGINSMAGM | 926 | O14497 | |
| SQGPGPNMGKGGEQM | 351 | P35414 | |
| AMMGGQPSGFSQPVI | 531 | P98082 | |
| VFPQAGNLMPMGPGH | 711 | Q92585 | |
| FPSIVGRPRQQGMMG | 731 | A5A3E0 | |
| GAMGINNRGAMPPAP | 391 | Q15233 | |
| QNAGMMGIGPSQNPG | 831 | Q96JK9 | |
| NNASGMGGHRMFPGP | 81 | Q8N2X6 | |
| PVGQPMGMARAAAGP | 4366 | Q9Y6V0 | |
| LGMNMGGAPAGPAGT | 1836 | Q96JB1 | |
| MAAPLGGMFSGQPPG | 1 | Q9H204 | |
| MLVLPGMFNNAGVGA | 1566 | Q9C091 | |
| DPLGGLADMFGQMPG | 366 | P78344 | |
| MSRPGHGGLMPVNGL | 1 | Q86Y01 | |
| QMMPGPVGGFGPMIS | 181 | Q9BRQ0 | |
| PVGGFGPMISPTMGQ | 186 | Q9BRQ0 | |
| PMPGVAGGSGQSKVM | 496 | Q8IZL2 | |
| FPSIVGRPRQQGMMG | 731 | Q6S8J3 | |
| PGMAQGMEPGAGQEG | 131 | Q86VX9 | |
| TQAMKMGLGGNPYGP | 1676 | Q8NCM8 | |
| MGTQDPGNMGTGVPA | 1 | Q9HCG7 | |
| GAMGAVNGMQPHGVP | 796 | Q9HCG7 | |
| PSGMGPLFMNGLIAG | 2461 | Q8TD26 | |
| MFGGPGPGVLGAQGM | 1 | Q9BQN1 | |
| QGPSGLSIQGMPGMP | 1506 | Q05707 | |
| MILEGGGVMNLNPGN | 1 | Q9NZC4 | |
| PGSQMRLPGFAGMIN | 556 | O00512 | |
| MGGFSQGPGNPGNMM | 1411 | O00512 | |
| IQIMCAMGPPGGGRN | 2086 | Q8WXX0 | |
| MPGPQGGRGAATMSL | 1 | Q00587 | |
| GQQGKKGAPGMPGLM | 626 | Q96P44 | |
| MPGLMGSNGSPGQPG | 636 | Q96P44 | |
| MSGPNGDLGMPVEAG | 1 | Q9BUW7 | |
| MEQAMPGAGPGVPQL | 26 | Q96JQ5 | |
| TPGGAMQPQLGMPGV | 281 | Q9H0L4 | |
| LTLMANGMPLPGGGT | 186 | A6NKP2 | |
| FLMAAMGPPGGGRTV | 2526 | Q9P225 | |
| AMNNLGMVPVGLPGQ | 51 | Q8TC92 | |
| MNFLRGVMGGQSAGP | 1 | O60763 | |
| HVGQGAPGLMGNMNP | 36 | Q8NHV9 | |
| APGLMGNMNPEGGVN | 41 | Q8NHV9 | |
| AADMGNPVGQSGLGM | 441 | Q9UBV2 | |
| NGGNVQGHLPLMPMS | 601 | P28749 | |
| PGEIPMGMGANPYGQ | 986 | Q9Y6Q9 | |
| GPVMPGNPLMAVGLA | 296 | Q8TE82 | |
| FPSIVGRPRQQGMMG | 731 | P0CG38 | |
| QVIMGPGTPMDGGSI | 1006 | Q9NZP6 | |
| MGPAGSLLGSGQMQI | 1 | Q9NWQ8 | |
| QGMMGLLGSPGHVFP | 176 | Q6PIS1 | |
| GLVPMGGVMSGAVPA | 96 | P52815 | |
| QEEMMAGNVYGLGPP | 246 | Q8IY92 | |
| PVGFIGLGNMGNPMA | 41 | P31937 | |
| GQMGMFNPMAIPFGA | 246 | Q9BZC1 | |
| FPPGMGQFMAGELMP | 406 | P35523 | |
| TGMIGYGIPPQMGSV | 606 | Q13492 | |
| PGMGLNQNRGPMGPG | 36 | P23246 | |
| MTMLLDGGPQFPGLG | 1 | O60481 | |
| FGGLLGPMDEPVGMQ | 756 | Q86Y38 | |
| AGPGLPAMNMGPGVR | 226 | Q9BWG4 | |
| VVGPQGGMVGQMGAP | 391 | Q8IYB5 | |
| FLGMNPGPFGMAQTG | 81 | Q53HV7 | |
| VPAGMNPTGIGGVMG | 206 | Q8NF64 | |
| GGVMGPSGLSPLAMN | 216 | Q8NF64 | |
| FPGGLMGPVRMISSG | 1271 | Q70CQ2 | |
| GPGPKMVAMQNYHGN | 586 | P52735 | |
| GGHMSLMLPGYNQPA | 841 | Q9Y4E6 | |
| VNATLMQPGVNGPMG | 546 | Q8NDV7 | |
| PNGPQGAGAVQFMMT | 6 | P57088 |